Fate Therapeutics reports trial data on autoimmune treatments

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. MU
5. ACN
6. NVDA
7. IBM
8. PRIM
9. SPY
10. DPZ

Go back to Fate Therapeutics reports trial data on autoimmune treatments
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 2.10 -0.05 (2.33%)
Previous Close $2.15    52 Week High $4.76 
Open $2.10    52 Week Low $1.46 
Day High $2.32    P/E N/A 
Day Low $2.07    EPS $-1.91 
Volume 2,672,425